Detalhe da pesquisa
1.
BRAF V600E is associated with higher incidence of second cancers in adults with Langerhans cell histiocytosis.
Blood
; 142(18): 1570-1575, 2023 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37595284
2.
Impact of etoposide and ASCT on survival among patients aged <65 years with stage II to IV PTCL: a population-based cohort study.
Blood
; 140(9): 1009-1019, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35544601
3.
Outcome of combined modality treatment in first-line for stage I(E) peripheral T-cell lymphoma; a nationwide population-based cohort study from the Netherlands.
Haematologica
; 109(4): 1163-1170, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37794805
4.
Autonomous B-cell receptor signaling and genetic aberrations in chronic lymphocytic leukemia-phenotype monoclonal B lymphocytosis in siblings of patients with chronic lymphocytic leukemia.
Haematologica
; 109(3): 824-834, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37439337
5.
The Genetic Profile of Large B-Cell Lymphomas Presenting in the Ocular Adnexa.
Int J Mol Sci
; 25(6)2024 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38542066
6.
Detection of Second Primary Lymphoma in Late Diffuse Large B-cell Lymphoma Recurrences.
Mod Pathol
; 36(5): 100119, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36805792
7.
IGLV3-21*01 is an inherited risk factor for CLL through the acquisition of a single-point mutation enabling autonomous BCR signaling.
Proc Natl Acad Sci U S A
; 117(8): 4320-4327, 2020 02 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32047037
8.
High frequency of inactivating tetraspanin C D37 mutations in diffuse large B-cell lymphoma at immune-privileged sites.
Blood
; 134(12): 946-950, 2019 09 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31366619
9.
Treatment of patients with MYC rearrangement positive large B-cell lymphoma with R-CHOP plus lenalidomide: results of a multicenter HOVON phase II trial.
Haematologica
; 105(12): 2805-2812, 2020 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33256379
10.
MYD88 in the driver's seat of B-cell lymphomagenesis: from molecular mechanisms to clinical implications.
Haematologica
; 104(12): 2337-2348, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31699794
11.
Outcomes of rare patients with a primary cutaneous CD30+ lymphoproliferative disorder developing extracutaneous disease.
Blood
; 135(10): 769-773, 2020 03 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31977038
12.
High prevalence of MYD88 and CD79B mutations in intravascular large B-cell lymphoma.
Blood
; 131(18): 2086-2089, 2018 05 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29514783
13.
Sinonasal DLBCL: molecular profiling identifies subtypes with distinctive prognosis and targetable genetic features.
Blood Adv
; 8(8): 1946-1957, 2024 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38324724
14.
Antigen-independent, autonomous B cell receptor signaling drives activated B cell DLBCL.
J Exp Med
; 221(5)2024 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38512136
15.
Treatment strategies and outcome in relapsed peripheral T-cell lymphoma: results from the Netherlands Cancer Registry.
Blood Adv
; 2024 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38739705
16.
The degree of HLA matching determines the incidence of cytokine release syndrome and associated nonrelapse mortality in matched related and unrelated allogeneic stem cell transplantation with post-transplant cyclophosphamide.
Leuk Lymphoma
; : 1-11, 2024 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38710017
17.
A population-based study of transformed marginal zone lymphoma: identifying outcome-related characteristics.
Blood Cancer J
; 13(1): 130, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37658062
18.
Development of a Core Set of Patient- and Caregiver-Reported Signs and Symptoms to Facilitate Early Recognition of Acute Chimeric Antigen Receptor T-Cell Therapy Toxicities.
JCO Oncol Pract
; 19(3): e407-e416, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36508702
19.
Genomic profiling of post-transplant lymphoproliferative disorders using cell-free DNA.
J Hematol Oncol
; 16(1): 104, 2023 09 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37705050
20.
A non-randomized risk-adjusted comparison of lenalidomide + R-CHOP versus R-CHOP for MYC-rearranged DLBCL patients.
Blood Cancer J
; 13(1): 85, 2023 05 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37217463